05Jan 2015
Cell biologists at UT Southwestern Medical Center have targeted telomeres with a small molecule called 6-thiodG that takes advantage of the cell’s ‘biological clock’ to kill cancer cells and shrink tumor growth.
Medical News – Taj Ando Pharmaceuticals, South Africa | Newsroom, current medical news, Taj Africa , alternative medicine magazine, regional news, surgical equipment, manufactures, ayurvedic healing, medical health news, pharmaceutical sales, pharmaceutical software, biotech consulting, pharmaceuticals news, pharmaceutical contract manufacturing, television stations news, medicines inspection, process validation, manufacturer of pharmaceuticals, pharmaceutical development, new medical products, pharma marketing, news station, exporter & supplier of Pharma Product, buyer, medicines, pharmaceutical manufacturing, pharmaceutical export, products news, generics manufactures, exporter directory, traders in India, vendors, Pharma Connections, Worldwide, producers, Product Online Supplies from Africa
Medical News – Taj Ando Pharmaceuticals, South Africa | Newsroom, current medical news, Taj Africa , alternative medicine magazine, regional news, surgical equipment, manufactures, ayurvedic healing, medical health news, pharmaceutical sales, pharmaceutical software, biotech consulting, pharmaceuticals news, pharmaceutical contract manufacturing, television stations news, medicines inspection, process validation, manufacturer of pharmaceuticals, pharmaceutical development, new medical products, pharma marketing, news station, exporter & supplier of Pharma Product, buyer, medicines, pharmaceutical manufacturing, pharmaceutical export, products news, generics manufactures, exporter directory, traders in India, vendors, Pharma Connections, Worldwide, producers, Product Online Supplies from Africa
Medical News – Taj Ando Pharmaceuticals, South Africa | Newsroom, current medical news, Taj Africa , alternative medicine magazine, regional news, surgical equipment, manufactures, ayurvedic healing, medical health news, pharmaceutical sales, pharmaceutical software, biotech consulting, pharmaceuticals news, pharmaceutical contract manufacturing, television stations news, medicines inspection, process validation, manufacturer of pharmaceuticals, pharmaceutical development, new medical products, pharma marketing, news station, exporter & supplier of Pharma Product, buyer, medicines, pharmaceutical manufacturing, pharmaceutical export, products news, generics manufactures, exporter directory, traders in India, vendors, Pharma Connections, Worldwide, producers, Product Online Supplies from Africa
01Sep 2014
People with high cholesterol are at risk of heart attack and stroke because atherosclerotic plaques within their arteries can rupture triggering the formation of a blood clot called an occlusive thrombus that cuts off the blood supply to their heart or brain.
People with high cholesterol are at risk of heart attack and strokeFor years, scientists have studied the cause of this abnormal clotting. Now, a study led by researchers from the University of North Carolina at Chapel Hill School of Medicine, has identified a molecular pathway that leads to this abnormal blood clotting and turned it off using a popular class of cholesterol-lowering drugs, statins.
The research was performed using humans, monkeys and mice with highly elevated blood lipid levels. It indicated that elevated levels of oxidized low density lipoprotein (LDL) induces a molecule called “tissue factor” that triggers clotting. The study appears online in the January 3, 2012 issue of the Journal of Clinical Investigation. Continue reading
27Aug 2014
Hugely popular non-steroidal anti-inflammation drugs like aspirin, naproxen and ibuprofen all work by inhibiting or killing an enzyme called cyclooxygenase – a key catalyst in production of hormone-like lipid compounds called prostaglandins that are linked to a variety of ailments, from headaches and arthritis to menstrual cramps and wound sepsis.
In a new paper, published this week in the online early edition of PNAS, researchers at the University of California, San Diego School of Medicine conclude that aspirin has a second effect: Not only does it kill cyclooxygenase, thus preventing production of the prostaglandins that cause inflammation and pain, it also prompts the enzyme to generate another compound that hastens the end of inflammation, returning the affected cells to homeostatic health.
Recent Comments